CVS Health Shares Jump Over 3% as Q1 Profit Rises 66% and Guidance Improves
Updated
Updated · The Motley Fool · May 12
CVS Health Shares Jump Over 3% as Q1 Profit Rises 66% and Guidance Improves
7 articles · Updated · The Motley Fool · May 12
CVS shares climbed more than 3% Tuesday, outperforming a falling S&P 500 after investors digested stronger first-quarter results and fresh analyst support.
Nearly $3 billion in Q1 net income—up 66% from a year earlier—helped drive the move, while CVS also cut its medical benefit ratio by almost 3 percentage points and lifted its 2026 profitability outlook.
J.P. Morgan raised its price target to $111 from $101, and another analyst lifted his to $106 from $94; both kept buy-equivalent ratings.
The rally suggests investors are warming to CVS's mix of pharmacy, retail healthcare and insurance operations as management shows improving cost control and earnings momentum.
With new regulations targeting its core business, can CVS's integrated health empire sustain its powerful momentum?
As CVS profits from 'efficiency,' will patients see lower healthcare costs or just higher returns for shareholders?